Purchase Order 75N91018P00433

The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. valued at $19,429.50 on June 11, 2018, for firm fixed price delivery completing July 6, 2018. Place of performance is Bethesda, Maryland. No set-aside was used. The order procures analytical laboratory instruments, consumables, or maintenance services consistent with Agilent's role as a supplier of gas chromatography-mass spectrometry systems, liquid chromatography-mass spectrometry equipment, and associated...

The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $16,018.50 on January 31, 2018, with an ultimate completion date of January 25, 2019. The order carries fixed-price pricing with economic price adjustment and no set-aside designation. Place of performance is Bethesda, Maryland. The purchase order procures analytical laboratory instruments and associated consumables or services, consistent with Agilent's role as a supplier of gas chromatography-mass...

The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. valued at $17,852.40 on August 23, 2018, with ultimate completion on August 23, 2019. The order carries fixed-price pricing with economic price adjustment and no set-aside designation. Place of performance is Bethesda, Maryland. The purchase order procures analytical laboratory instrumentation, consumables, or maintenance services typical of Agilent's federal portfolio in analytical chemistry equipment supply.

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. valued at $17,430.36 on May 24, 2018, with ultimate completion on June 23, 2018. No set-aside was used. Place of performance is Bethesda, Maryland. The order procures analytical laboratory instrumentation or consumables; the specific product line is not identified in the award record.</p>

<p>The National Cancer Institute issued a purchase order to Agilent Technologies Inc. valued at $12,914.00 on July 20, 2017, with an ultimate completion date of July 19, 2018. Place of performance is San Diego, California. The order carries firm fixed price pricing with no set-aside designation. The procurement covers analytical laboratory instruments and associated consumables or services typical of Agilent's federal equipment and maintenance portfolio.</p>

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. valued at $5,124.04 on May 15, 2018, with ultimate completion on June 30, 2019. No set-aside was used. Place of performance is Bethesda, Maryland. The order is firm fixed price.</p>

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $17,948.50 on September 19, 2019, for drugs and biologicals, with ultimate completion on October 19, 2019. Place of performance is Bethesda, Maryland. The order uses firm fixed-price pricing with no set-aside category.</p>

The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $18,781.20 on May 31, 2018, with an ultimate completion date of May 31, 2019. No set-aside was used. Performance takes place in Marshallton, Delaware. The order is for firm fixed price supply of analytical laboratory instruments and associated consumables from Agilent's Customer Service and Sales Division, a manufacturer of gas chromatography-mass spectrometry systems, liquid chromatography-mass...

The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $12,904.00, with an award date of August 22, 2017 and ultimate completion on September 22, 2017. Performance takes place in Marshallton, Delaware. The order is a firm fixed price procurement for analytical laboratory equipment or consumables, consistent with Agilent's role as a supplier of gas chromatography-mass spectrometry systems, liquid chromatography-mass spectrometry equipment, and associated...

The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for a maintenance agreement valued at $17,982.00, effective August 22, 2019, with ultimate completion August 23, 2020. Place of performance is Bethesda, Maryland. The order uses fixed price with economic price adjustment pricing. No set-aside was used. The work covers maintenance services for Agilent analytical laboratory instrumentation, consistent with Agilent's CrossLab maintenance service model sustaining the...